Your browser doesn't support javascript.
loading
Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley, Carlos W; Colón, David F; Luiz, João Paulo M; Oliveira, Francisco F; Viacava, Paula R; Leite, Caio A; Pereira, Janaina A; Silva, Camila M; Silva, Cassia R; Silva, Rangel L; Speck-Hernandez, Cesar A; Mota, José M; Alves-Filho, José C; Lima-Junior, Roberto C; Cunha, Thiago M; Cunha, Fernando Q.
Affiliation
  • Wanderley CW; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil. fdqcunha@fmrp.usp.br thicunha@fmrp.usp.br robertocesar@ufc.br carloswagner@alu.ufc.br.
  • Colón DF; Department Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.
  • Luiz JPM; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Oliveira FF; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Viacava PR; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Leite CA; Department Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.
  • Pereira JA; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Silva CM; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Silva CR; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Silva RL; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Speck-Hernandez CA; Department Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.
  • Mota JM; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Alves-Filho JC; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Lima-Junior RC; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Cunha TM; Sao Paulo State Cancer Institute, University of Sao Paulo, Sao Paulo, Brazil.
  • Cunha FQ; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Cancer Res ; 78(20): 5891-5900, 2018 10 15.
Article in En | MEDLINE | ID: mdl-30104241
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Toll-Like Receptor 4 / Macrophages / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Toll-Like Receptor 4 / Macrophages / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2018 Document type: Article Country of publication: United States